Shanghai Fosun Pharmaceutical : POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2020 SECOND EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 9 OCTOBER 2020 (H SHARES)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

上 海 復 星 醫 藥（ 集 團 ）股 份 有 限 公 司

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 02196)

POLL RESULTS OF THE RESOLUTIONS PROPOSED AT

THE 2020 SECOND EXTRAORDINARY GENERAL MEETING HELD ON

FRIDAY, 9 OCTOBER 2020

The board (the ''Board'') of directors (the ''Directors'') of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (the ''Company'') is pleased to announce the poll results of the 2020 second extraordinary general meeting (the ''EGM'') held at Shanghai Film Art Center, No. 160 Xinhua Road, Shanghai, the PRC on Friday, 9 October 2020 at 1:30 p.m..

References are made to the notice of the EGM and the circular of the Company (the ''Circular''), both dated 11 September 2020. Unless the context otherwise specified, capitalized terms used in this announcement shall have the same meanings as those defined in the Circular.

As at the date of the EGM, (i) the total number of the issued shares of the Company (the ''Shares'') was 2,562,898,545 Shares, comprising 2,010,958,045 A Shares and 551,940,500 H Shares; and (ii) holders of 2,562,898,545 Shares (or authorized proxies) were entitled to attend and vote on the resolutions proposed at the EGM. There were no Shares entitling the shareholders of the Company (the ''Shareholders'') to attend and vote only against the resolutions at the EGM.

To the best of the Directors' knowledge, information and belief, having made all reasonable enquiries, no Shareholder was required to abstain from voting at the EGM.

- 1 -

ATTENDANCE AT THE EGM

Set out below are the details of the Shareholders and authorized proxies present at the EGM:

Number of Shareholders and authorized proxies	229
Including:	Number of A Shareholders	228
	Number of H Shareholders	1
Total number of Shares carrying voting rights (shares)	1,198,716,277
Including:	Total number of Shares carrying voting rights held by	1,007,465,504
	A Shareholders
	Total number of Shares carrying voting rights held by	191,250,773
	H Shareholders
Percentage of the total number of Shares	46.7719%
Including:	Number of A Shares as a percentage of the number of Shares	39.3096%
	Number of H Shares as a percentage of the number of Shares	7.4623%

The EGM was convened in compliance with the requirements of the Company Law and the Articles of Association, and was chaired by Mr. Chen Qiyu, chairman of the Company.

In compliance with the requirements of the Hong Kong Listing Rules and Article 115 of the Articles of Association, BDO Limited, Grandall Law Firm (Shanghai)* (國浩律師(上海)事務所), the Company's PRC legal advisers, Shareholder's representatives and members of the supervisory committee of the Company acted as the scrutineers for the vote-counting at EGM.

POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE EGM

All resolutions at the EGM were voted by poll. The poll results in respect of the resolutions proposed at the EGM are as follows:

	SPECIAL RESOLUTIONS	Number of valid votes
	For	Against	Abstain
1.	To consider and approve the proposed	1,198,407,225	309,052	0
	amendments to the Articles of Association.	(99.9742%)	(0.0258%)	(0.0000%)

As more than two-thirds of the votes were cast in favour of this resolution, the resolution was duly passed as a special resolution.

2.	To consider and approve the proposed	1,198,634,225	82,052	0
	amendments to the Procedural Rules for	(99.9932%)	(0.0068%)	(0.0000%)
	General Meetings.

As more than two-thirds of the votes were cast in favour of this resolution, the resolution was duly passed as a special resolution.

- 2 -

	SPECIAL RESOLUTIONS	Number of valid votes
	For	Against	Abstain
3.	To consider and approve the proposed	1,198,634,225	75,252	6,800
	amendments to the Procedural Rules of the	(99.9932%)	(0.0063%)	(0.0005%)
	Board.

As more than two-thirds of the votes were cast in favour of this resolution, the resolution was duly passed as a special resolution.

	ORDINARY RESOLUTION	Number of valid votes
	For	Against	Abstain
4.	To elect Mr. Zhang Houlin as a non-executive	1,172,856,396	25,859,881	0
	Director.	(97.8427%)	(2.1573%)	(0.0000%)

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

CERTIFICATION

As certified by and stated in the legal opinion issued by Grandall Law Firm (Shanghai)* (國浩律師(上海)事務所), the Company's PRC legal advisers, the convening and holding of the EGM are in compliance with requirements of the relevant laws, administrative regulations, the Rules of General Meetings of Listed Companies and the Articles of Association, the qualifications of the attendees of the EGM and the convener are legally valid, and the voting procedures and voting results of the EGM are legally valid.

ELECTION OF NON-EXECUTIVE DIRECTOR

At the EGM, Mr. Zhang Houlin was duly elected by the Shareholders as a non-executive Director of the eighth session of the Board. The appointment of Mr. Zhang Houlin shall be effective from 9 October 2020 until the term of the current session of the Board expires.

- 3 -

Information including the biographies, length of service and emolument of Mr. Zhang Houlin were set out in the Circular. Save as disclosed in the Circular, as at the date of this announcement, there is no information in relation to Mr. Zhang Houlin which is required to be disclosed pursuant to Rule 13.51(2) of the Hong Kong Listing Rules, nor are there other matters in relation to his appointment that need to be brought to the attention of the Shareholders.

By order of the Board

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*

Chen Qiyu

Chairman

Shanghai, the PRC

9 October 2020

As at the date of this announcement, the executive directors of the Company are Mr. Chen Qiyu, Mr. Yao Fang and Mr. Wu Yifang; the non-executive directors of the Company are Mr. Xu Xiaoliang, Mr. Gong Ping, Mr. Pan Donghui and Mr. Zhang Houlin; and the independent non-executive directors of the Company are Mr. Jiang Xian, Dr. Wong Tin Yau Kelvin, Ms. Li Ling and Mr. Tang Guliang.

• for identification purposes only

- 4 -